OUP Management as of Sept. 30, 2023
Portfolio Holdings for OUP Management
OUP Management holds 12 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals Sponsored ADS (CNTA) | 42.7 | $19M | 2.9M | 6.47 | |
| Aerovate Therapeutics Common Stock (AVTE) | 18.4 | $8.2M | 604k | 13.57 | |
| Cyteir Therapeutics Common Stock | 15.7 | $7.0M | 2.5M | 2.84 | |
| PMV Pharmaceuticals Common Stock (PMVP) | 13.7 | $6.1M | 989k | 6.14 | |
| Graphite Bio Common Stock | 2.3 | $1.0M | 406k | 2.48 | |
| Selecta Biosciences Common Stock (RNAC) | 2.1 | $914k | 863k | 1.06 | |
| Vor Biopharma Common Stock (VOR) | 1.8 | $794k | 375k | 2.12 | |
| eFFECTOR Therapeutics Common Stock | 1.4 | $615k | 1.0M | 0.60 | |
| Precision BioSciences Common Stock | 0.9 | $384k | 1.1M | 0.34 | |
| Spero Therapeutics Common Stock (SPRO) | 0.7 | $301k | 249k | 1.21 | |
| Ikena Oncology Common Stock (IKNA) | 0.3 | $116k | 27k | 4.33 | |
| Homology Medicines Common Stock | 0.2 | $75k | 64k | 1.17 |
